Larson Financial Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.2K | Sell |
5,444
-24
| -0.4% | -$371 | ﹤0.01% | 901 |
|
|
2025
Q1 | $81.3K | Buy |
5,468
+496
| +10% | +$7.38K | ﹤0.01% | 850 |
|
|
2024
Q4 | $65.8K | Hold |
4,972
| – | – | ﹤0.01% | 820 |
|
|
2024
Q3 | $70.7K | Buy |
4,972
+485
| +11% | +$6.9K | ﹤0.01% | 803 |
|
|
2024
Q2 | $58.1K | Hold |
4,487
| – | – | ﹤0.01% | 774 |
|
|
2024
Q1 | $62.3K | Sell |
4,487
-3,675
| -45% | -$51K | ﹤0.01% | 639 |
|
|
2023
Q4 | $116K | Buy |
+8,162
| New | +$116K | 0.01% | 460 |
|
|
2022
Q2 | – | Sell |
-410
| Closed | -$6K | – | 1289 |
|
|
2022
Q1 | $6K | Hold |
410
| – | – | ﹤0.01% | 774 |
|
|
2021
Q4 | $6K | Buy |
410
+10
| +3% | +$146 | ﹤0.01% | 786 |
|
|
2021
Q3 | $7K | Hold |
400
| – | – | ﹤0.01% | 653 |
|
|
2021
Q2 | $7K | Buy |
+400
| New | +$7K | ﹤0.01% | 612 |
|
|
2019
Q4 | – | Sell |
-70
| Closed | -$1K | – | 660 |
|
|
2019
Q3 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 516 |
|